SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001520138-18-000269
Filing Date
2018-10-05
Accepted
2018-10-05 14:35:27
Documents
49
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR PERIOD JUNE 30, 2018 bivi-20180630_10k.htm 10-K 559253
2 EXHIBIT 31.1 bivi-20180630_10kex31z1.htm EX-31.1 12386
3 EXHIBIT 31.2 bivi-20180630_10kex31z2.htm EX-31.2 12378
4 EXHIBIT 32.1 bivi-20180630_10kex32z1.htm EX-32.1 6006
5 EXHIBIT 32.2 bivi-20180630_10kex32z2.htm EX-32.2 5978
6 GRAPHIC image_001.jpg GRAPHIC 30009
7 GRAPHIC image_002.gif GRAPHIC 10419
8 GRAPHIC image_002.jpg GRAPHIC 2160
  Complete submission text file 0001520138-18-000269.txt   2204931

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE FILE bivi-20180630.xml EX-101.INS 273536
10 XBRL SCHEMA FILE bivi-20180630.xsd EX-101.SCH 23921
11 XBRL CALCULATION FILE bivi-20180630_cal.xml EX-101.CAL 35729
12 XBRL DEFINITION FILE bivi-20180630_def.xml EX-101.DEF 63434
13 XBRL LABEL FILE bivi-20180630_lab.xml EX-101.LAB 189716
14 XBRL PRESENTATION FILE bivi-20180630_pre.xml EX-101.PRE 138174
Mailing Address 100 CUMMINGS CENTER, SUITE 247-C BEVERLY MA 01915
Business Address 100 CUMMINGS CENTER, SUITE 247-C BEVERLY MA 01915 312-283-5793
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

IRS No.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-55292 | Film No.: 181110280
SIC: 2834 Pharmaceutical Preparations